MetaCap

Parabilis Medicines Statistics

NASDAQ: PBLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

27.44-0.185 (-0.67%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Parabilis Medicines by the numbers

Parabilis Medicines has a market capitalization of $3.44 billion based on 123.68M shares outstanding. With trailing EPS of $-3.62, Parabilis Medicines is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.0% below its 50-day average and 13.6% below its 200-day average.

Average daily trading volume is 975.55K shares, or about $26.8 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

PBLS valuation vs. peer median

PBLS compared with the median of 8 peer companies
MetricPBLSPeer medianDifference
Market cap$3.44B$3.41B+1%
Avg. volume975.55K1.92M-49%

Peer median across 8 companies: IRON, ELVN, VRDN, AMLX, ARQT, XENE, OGN, ABCL.

Valuation

Price and trading

Previous close
27.63
Open
27.09
Day range
26.50 – 28.52
52-week range
22.66 – 42.49
Beta
—
Volume
1.25M

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
3.44B
Forward Pe
-11.69
Eps
-3.62
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
42.49
Week52 Low
22.66
Avg Volume
975.55K
Shares Outstanding
123.68M
Ma50
29.83
Ma200
31.75
Earnings Date
Nov 12, 2026
Pct From52w High
-35.42%
Pct From52w Low
21.09%

Related